CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 11.39 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $82,295,364 | 16.57% |
CHI Advisors LLC | 3,414,189 | $36,736,673 | 11.15% |
Nextech Invest Ltd. | 1,221,145 | $13,139,520 | 4.47% |
BVF INC/IL | 3,196,701 | $34,396,503 | 0.96% |
Lynx1 Capital Management LP | 115,063 | $1,238,078 | 0.81% |
TANG CAPITAL MANAGEMENT LLC | 450,000 | $4,842,000 | 0.71% |
BRAIDWELL LP | 1,908,865 | $20,539,387 | 0.67% |
Parkman Healthcare Partners LLC | 346,781 | $3,731,364 | 0.65% |
Boxer Capital, LLC | 1,074,082 | $11,557 | 0.54% |
Velan Capital Investment Management LP | 50,000 | $538,000 | 0.50% |
Rubric Capital Management LP | 626,929 | $6,745,756 | 0.29% |
SVB FINANCIAL GROUP | 13,516 | $145,432 | 0.28% |
Birchview Capital, LP | 25,114 | $270,227 | 0.20% |
KENNEDY CAPITAL MANAGEMENT LLC | 541,922 | $5,831,081 | 0.14% |
Orbimed Advisors | 544,848 | $5,862,564 | 0.11% |
Artal Group S.A. | 250,000 | $2,690 | 0.08% |
AMERICAN INTERNATIONAL GROUP, INC. | 1,235,169 | $13,290,418 | 0.08% |
Virtus ETF Advisers LLC | 9,239 | $99,412 | 0.06% |
CORNERCAP INVESTMENT COUNSEL INC | 18,795 | $202,234 | 0.04% |
Verition Fund Management LLC | 221,111 | $2,379,154 | 0.03% |
External links
This page lists CULLINAN ONCOLOGY INC's shareholders in Q2 2023. To view CULLINAN ONCOLOGY INC's shareholder history, click here.